Value-based care is reshaping how diagnostic imaging is reimbursed, evaluated, and procured. Hospital systems and health networks are demanding evidence of clinical value — outcomes improvement, dose reduction, workflow efficiency, and reduced downstream costs — from imaging equipment investments. Dose monitoring and management, appropriateness criteria for imaging utilization, and radiology performance metrics are becoming standard components of capital procurement decisions.
Topics Covered
• Value-Based Imaging Frameworks
• Dose Optimization and Monitoring
• Appropriateness Criteria and Clinical Decision Support
• Radiology Quality Metrics
• Bundled Payment Impact on Imaging
• OEM Value Proposition Evolution
• Total Cost of Ownership Analysis
Table of Contents
1. Executive Summary
2. Market Overview
3. Value-Based Imaging Frameworks
4. Dose Optimization and Monitoring
5. Appropriateness Criteria and Clinical Decision Support
6. Radiology Quality Metrics
7. Bundled Payment Impact on Imaging
8. OEM Value Proposition Evolution
9. Total Cost of Ownership Analysis
10. Regional Market Analysis
11. Strategic Conclusions and Recommendations
12. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Canon Medical
Esaote
Fujifilm Healthcare
GE HealthCare
Hologic
Mindray
Philips
Samsung Medison
Shimadzu
Siemens Healthineers
